Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BioSig Technologies stock | $4.57

Own BioSig Technologies stock in just a few minutes.

Fact checked

BioSig Technologies, Inc is a medical devices business based in the US. BioSig Technologies shares (BSGM) are listed on the NASDAQ and all prices are listed in US Dollars. BioSig Technologies employs 33 staff and has a market cap (total outstanding shares value) of USD$133.4 million.

How to buy shares in BioSig Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for BioSig Technologies. Find the stock by name or ticker symbol: BSGM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until BioSig Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$4.57, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of BioSig Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of BioSig Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

BioSig Technologies share price

Use our graph to track the performance of BSGM stocks over time.

BioSig Technologies shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$4.57
52-week rangeUSD$2.36 - USD$12.43
50-day moving average USD$4.3281
200-day moving average USD$6.3514
Wall St. target priceUSD$13
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.299

Buy BioSig Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioSig Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioSig Technologies price performance over time

Historical closes compared with the close of $4.57 from 2020-12-09

1 week (2021-01-15) -5.19%
1 month (2020-12-23) -0.22%
3 months (2020-10-23) -8.96%
6 months (2020-07-23) -41.71%
1 year (2020-01-23) -17.36%
2 years (2019-01-23) 6.78%
3 years (2018-01-23) 221.83%
5 years (2016-01-22) 187.42%

BioSig Technologies financials

Gross profit TTM USD$0
Return on assets TTM -161.38%
Return on equity TTM -297.6%
Profit margin 0%
Book value $0.948
Market capitalisation USD$133.4 million

TTM: trailing 12 months

Shorting BioSig Technologies shares

There are currently 2.5 million BioSig Technologies shares held short by investors – that's known as BioSig Technologies's "short interest". This figure is 9.7% down from 2.7 million last month.

There are a few different ways that this level of interest in shorting BioSig Technologies shares can be evaluated.

BioSig Technologies's "short interest ratio" (SIR)

BioSig Technologies's "short interest ratio" (SIR) is the quantity of BioSig Technologies shares currently shorted divided by the average quantity of BioSig Technologies shares traded daily (recently around 312529.92424242). BioSig Technologies's SIR currently stands at 7.92. In other words for every 100,000 BioSig Technologies shares traded daily on the market, roughly 7920 shares are currently held short.

However BioSig Technologies's short interest can also be evaluated against the total number of BioSig Technologies shares, or, against the total number of tradable BioSig Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioSig Technologies's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 BioSig Technologies shares in existence, roughly 80 shares are currently held short) or 0.093% of the tradable shares (for every 100,000 tradable BioSig Technologies shares, roughly 93 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against BioSig Technologies.

Find out more about how you can short BioSig Technologies stock.

BioSig Technologies share dividends

We're not expecting BioSig Technologies to pay a dividend over the next 12 months.

Have BioSig Technologies's shares ever split?

BioSig Technologies's shares were split on a 2:5 basis on 11 September 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your BioSig Technologies shares – just the quantity. However, indirectly, the new 150% higher share price could have impacted the market appetite for BioSig Technologies shares which in turn could have impacted BioSig Technologies's share price.

BioSig Technologies share price volatility

Over the last 12 months, BioSig Technologies's shares have ranged in value from as little as $2.36 up to $12.43. A popular way to gauge a stock's volatility is its "beta".

BSGM.US volatility(beta: 1.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioSig Technologies's is 1.8777. This would suggest that BioSig Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioSig Technologies overview

BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site